Litigation
Sun Pharmaceutical Industries Ltd. et al. v. Solaris Pharma Corporation
pending2:26-cv-04286
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Filed
- 2026-04-22
Patents at issue (2)
Defendants (1)
Summary
Hatch-Waxman/DJ action filed by Sun against Solaris concerning Solaris's ANDA No. 220440 for bromfenac ophthalmic solution 0.075%, asserting U.S. Patent RE50,218, the reissue of the ’999 family, rather than the ’999 patent itself. The case was pending/just filed.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).